CV Sciences, Inc. Experts Contribute to Journal of Dietary Supplements First Special Issue on Cannabinoids Aug 13, 2020
CV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product Line Jul 29, 2020
CV Sciences, Inc. Announces Publication of Two Research Studies Demonstrating the Safety and Health Benefits of PlusCBD™ Products Jun 2, 2020
CV Sciences, Inc. Announces Plan to Adjourn Annual Meeting of Stockholders to June 16, 2020 May 20, 2020
CV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction May 20, 2020